F16.283
Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks)
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F16.283 refers to a condition where an individual develops a dependence on hallucinogenic substances, such as LSD or psilocybin, coupled with a persistent perception disorder commonly known as flashbacks. This condition can significantly impact daily functioning and mental health, often requiring comprehensive management and support.
Causes & Symptoms
Clinical Causes: Chronic use of hallucinogenic substances over extended periods Repeated exposure to hallucinogens leading to physiological and psychological dependence Genetic predisposition influencing susceptibility to substance dependence Environmental factors such as stress, trauma, or peer influence that promote substance use History of mental health disorders which may increase vulnerability
Key Symptoms: Experiencing vivid visual disturbances or illusions reminiscent of previous hallucinations Recurring perceptual impressions that occur weeks or months after drug use Altered sensory perceptions, such as intensified colors, sounds, or textures Persistent feelings of anxiety, paranoia, or depression Difficulties distinguishing between real and perceived stimuli cravings for the hallucinogenic substance and compulsive drug-seeking behavior Potential impact on cognitive functions like concentration, memory, or judgment
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a comprehensive clinical assessment including detailed medical and substance use history, mental health evaluation, and observation of symptoms. Diagnostic criteria focus on evidence of dependence on hallucinogens alongside the presence of persistent perceptual disturbances. Healthcare providers may utilize questionnaires and psychological tests to aid in diagnosis.
Treatment Protocols: Management typically includes a combination of the following approaches: - **Detoxification** to safely manage dependence under medical supervision - **Psychotherapy** such as cognitive-behavioral therapy (CBT) to address underlying psychological factors and develop coping strategies - **Support groups** to provide peer support and encouragement - **Medication** may be prescribed to manage symptoms of anxiety, depression, or other co-occurring mental health issues - **Long-term monitoring** to prevent relapse and ensure sustained recovery Rehabilitation programs may be recommended for individuals with severe dependence, and personalized treatment plans should be developed based on individual needs.
Clinical Advice & FAQs
Billing Guidance
Is F16.283 a billable ICD-10 code?
Yes, F16.283 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F16.283?
Clinical documentation must specify the nature of Hallucinogen dependence with hallucinogen persisting perception disorder (flashbacks) and any associated comorbidities for accurate reporting.
Cite this Clinical Reference